Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2608
https://www.valueinhealthjournal.com/article/S1098-3015(14)04557-4/fulltext
Title : Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04557-4&doi=10.1016/j.jval.2014.08.2608
First page : A379
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 310
Categories :
Tags :
Regions :
ViH Article Tags :